Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Explore why a budget calculator may be inaccurate and how to diagnose common sources of error, then implement corrective steps.
19,411 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Investors are torn over a high-growth AI stock. This article breaks down the split, lays out the bull case, and shows...
Institutional activity in Bitcoin ETFs is more nuanced than daily inflows suggest. This piece examines how market mak...
Investors are expanding beyond Vanguard in March 2026 as cost, access, and tool diversity drive choice. This report h...
Chasing overnight riches rarely pays off. This guide shows how to identify the fastest stock that could steadily grow...
A telecom stock this rose 19% over the past year, but a prominent fund sold out. Discover the drivers behind the move...
Huron's latest revenue milestone grabbed headlines, but a large fund still trimmed its position. This article breaks ...
Today’s rally in a leading off-price retailer highlights how earnings, margins, and guidance can move a stock. This a...
When the market pulls back, the smartest move isn’t panic selling. This guide reveals the best stocks after this sell...
A bold, income-focused play shows up when a wealth manager made million-for-a-6.4% yield bet on a senior loan ETF. Th...
Healthcare costs loom large for retirees and investors alike. This article argues that one AI-driven healthcare leade...
I used to be skeptical about SoundHound AI, but new developments and strategic moves are making me reconsider. This a...